Thrivent Financial for Lutherans
IRWD icon

Thrivent Financial for Lutherans’s Ironwood Pharmaceuticals IRWD Stock Holding History

Thrivent Financial for Lutherans’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-108,850
Closed -$482K – 2453
2024
Q4 		$482K Sell
108,850
-1,539
-1% -$6.24K ﹤0.01% 2266
2024
Q3 		$455K Sell
110,389
-5,734
-5% -$30.8K ﹤0.01% 2282
2024
Q2 		$757K Sell
116,123
-3,069
-3% -$21.7K ﹤0.01% 2015
2024
Q1 		$1.04M Sell
119,192
-3,236
-3% -$39.3K ﹤0.01% 1882
2023
Q4 		$1.4M Sell
122,428
-3,179
-3% -$31.4K ﹤0.01% 1629
2023
Q3 		$1.21M Sell
125,607
-3,682
-3% -$36.1K ﹤0.01% 1619
2023
Q2 		$1.38M Sell
129,289
-2,965
-2% -$31.9K ﹤0.01% 1596
2023
Q1 		$1.39M Sell
132,254
-4,636
-3% -$51.9K ﹤0.01% 1575
2022
Q4 		$1.7M Sell
136,890
-916
-0.7% -$10.4K ﹤0.01% 1362
2022
Q3 		$1.43M Sell
137,806
-13,334
-9% -$151K ﹤0.01% 1441
2022
Q2 		$1.74M Buy
+151,140
New +$1.78M ﹤0.01% 1317
2018
Q1 		– Sell
-204,635
Closed -$2.57M – 2016
2017
Q4 		$2.57M Hold
204,635
– – 0.01% 825
2017
Q3 		$2.7M Hold
204,635
– – 0.01% 774
2017
Q2 		$3.24M Hold
204,635
– – 0.01% 697
2017
Q1 		$2.92M Hold
204,635
– – 0.01% 720
2016
Q4 		$2.62M Hold
204,635
– – 0.01% 772
2016
Q3 		$2.72M Hold
204,635
– – 0.01% 774
2016
Q2 		$2.24M Sell
204,635
-222,561
-52% -$2.17M 0.01% 836
2016
Q1 		$3.91M Sell
427,196
-52,775
-11% -$435K 0.02% 681
2015
Q4 		$4.66M Hold
479,971
– – 0.02% 595
2015
Q3 		$4.19M Buy
479,971
+87,162
+22% +$813K 0.02% 602
2015
Q2 		$3.97M Hold
392,809
– – 0.02% 527
2015
Q1 		$5.26M Sell
392,809
-717
-0.2% -$9.41K 0.03% 475
2014
Q4 		$5.05M Sell
393,526
-9,313
-2% -$107K 0.03% 473
2014
Q3 		$4.37M Hold
402,839
– – 0.03% 507
2014
Q2 		$5.17M Buy
+402,839
New +$4.38M 0.03% 487

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Thrivent Financial for Lutherans's IRWD Position: Q1 2025 in Review

Thrivent Financial for Lutherans sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 108,850 shares — an estimated $482K sold.

Thrivent Financial for Lutherans first reported a position in IRWD in Q2 2014 and held it in 26 quarters. The position peaked at $5.26M in Q1 2015. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Thrivent Financial for Lutherans reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 108,850 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $482K.
  • Thrivent Financial for Lutherans first reported a position in Ironwood Pharmaceuticals in Q2 2014 and held it in 26 quarters.
  • Thrivent Financial for Lutherans's Ironwood Pharmaceuticals position peaked at $5.26M in Q1 2015.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2025, filed 13 May 2025.